Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meibomian Gland Probing vs Sham for Refractory MGD
NCT02256969Phase 4Completed
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sulfacetamide + prednisolone in meibomian gland dysfunction (MGD). Started Oct 2014; status: completed.
02
Drugs
sulfacetamide + prednisolone
03
Conditions
meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT02256969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256969.